Naples Doctor Faces Federal Civil Suit for Alleged False Claims

Federal authorities have filed a civil complaint against Dr. Kevin Rosenbach, a Naples-based allergy and immunology specialist, for allegedly defrauding Medicare Part B of over $1.9 million through false diagnosis practices.

According to documents filed in federal district court, the U.S. government claims Dr. Rosenbach knowingly submitted false claims for subcutaneous immune globulins, medications typically used to treat patients with immune deficiencies.

The complaint details how Rosenbach allegedly manipulated patient diagnoses by changing or adding a rare immunodeficiency disease to patient records when those individuals did not actually meet the clinical definition of the condition. This fraudulent practice was reportedly designed specifically to secure Medicare Part B coverage for treatments that would otherwise not qualify for reimbursement.

Federal prosecutors assert that through these falsified diagnoses, Dr. Rosenbach caused specialty pharmacies to unknowingly submit improper claims to Medicare for dispensing immune globulin treatments, resulting in significant financial losses to the federal healthcare program.

“The United States Attorney’s Office will vigorously pursue and prosecute those who violate the law and compromise the integrity of federally funded programs,” said U.S. Attorney Gregory W. Kehoe in a statement. “This action sends a message that our office will continue to protect Medicare funds and the valuable healthcare services the program provides.”

This case highlights the ongoing challenge of medical fraud within the Medicare system. Healthcare fraud costs taxpayers billions annually and diverts crucial resources from patients with legitimate medical needs. The Department of Health and Human Services has increasingly focused on identifying and prosecuting cases of deliberate misdiagnosis and improper billing practices.

Immune globulin therapy represents a particularly costly treatment area for Medicare. These treatments, which can cost thousands of dollars per dose, are typically reserved for patients with specific, verified immune disorders. The medications contain antibodies collected from thousands of blood donors and are used to boost the immune system in patients with genuine immunodeficiencies.

Investigators in this case appear to have identified a pattern of suspicious diagnoses that did not align with patients’ actual medical conditions or symptoms. The complaint suggests that Rosenbach’s alleged scheme may have persisted for some time before detection.

Medicare fraud cases involving physician diagnosis manipulation are particularly concerning to regulators because they potentially expose patients to unnecessary treatments. Immune globulin therapy, while beneficial for appropriate patients, carries risks including allergic reactions, kidney problems, and blood clots.

The Southwest Florida medical community, where Dr. Rosenbach practices, has seen several significant fraud cases in recent years. Federal authorities have stepped up enforcement in the region, which has historically been a hotspot for Medicare fraud due to its large population of retirees and Medicare beneficiaries.

If found liable in the civil case, Dr. Rosenbach could face substantial financial penalties, including treble damages under the False Claims Act. He could also potentially face exclusion from participation in federal healthcare programs, effectively ending his ability to treat Medicare and Medicaid patients.

The case remains ongoing, and as with all civil complaints, the allegations must be proven in court. Dr. Rosenbach has not yet filed a formal response to the government’s allegations, and the court has not made any determination regarding liability.

Healthcare providers nationwide will likely watch this case closely, as it represents the continued emphasis on fraud prevention in federal healthcare programs and the serious consequences for practitioners who violate Medicare’s billing regulations.